Trials / Completed
CompletedNCT00434395
Study Evaluating the Effects of MOA-728 on Cardiac Repolarization in Healthy Subjects
A Randomized, Double-Blind, Placebo- and Moxifloxacin (Open-Label)-Controlled, 4-Period Crossover Study of the Effects of a Single Dose of MOA-728 Infused Intravenously on Cardiac Repolarization in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Bausch Health Americas, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to assess the effects of MOA-728 on cardiac repolarization in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MOA-728 |
Timeline
- Start date
- 2007-03-01
- Completion
- 2007-10-01
- First posted
- 2007-02-13
- Last updated
- 2019-11-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00434395. Inclusion in this directory is not an endorsement.